期刊文献+

加替沙星治疗非结核性分枝杆菌性角膜炎的实验研究 被引量:2

Treatment of gatifloxacin for experimental non-tuberculous mycobacterial keratitis in rabbit
下载PDF
导出
摘要 目的探讨加替沙星对兔非结核分枝杆菌(NTM)性角膜炎的治疗效果。方法利用龟分枝杆菌建立兔NTM角膜炎模型,随机分为6组,分别使用加替沙星、左氧氟沙星、环丙沙星、阿米卡星及加替沙星联合阿米卡星进行治疗,平衡盐溶液(BSS)作为对照;观察治疗前后角膜浸润面积及临床表现的变化,并对治疗1周后的角膜病灶进行细菌定量分析。结果加替沙星可抑制角膜组织内NTM的生长,使NTM角膜炎角膜浸润面积明显减小,与阿米卡星联合使用可增强其抗菌作用。结论加替沙星是治疗NTM角膜炎的有效药物之一。 Objective Non-tuberculous mycobacterial (NTM) keratitis has been recognized with increasing incidence since the initial report in 1965. Medical therapy is often unsatisfactory because of resistance of pathogen to most conventional antibiotics, The newly-developed antimicrobial agents,including gatifloxacin and moxifloxacin,have been shown to be effective in the treatment of human systemic diseases caused by NTM. This paper was to study the effectiveness of gatifloxacin against NTM keratitis in rabbit model, Methods Forty-two New Zealand white rabbits underwent unilateral lamellar keratectomy using a manual corneal trephine followed by the placement of 10000 colony-forming units (CFUs) of log-phase NTM under each flap. Eyes with NTM keratitis (seven in each group) were divided into six groups randomly and topically treated by 0.3% gatifloxacin, 0. 3% levofloxacin,0. 3% eiprofloxacin,l% amikacin and the combination of 0. 3% gatifloxacin and 1% amikacin respectively, and BSS ( balanced salt solution) was used as negative control. Topical medicine was applied eight times per day, Ocular clinical manifestation was graded and cornea infiltration area was determined before treatment and 7 days after treatment. Quantitative mycobacterium cultures were performed l week after treatment. Results The mean stromal infiltration area after treatment by gatifloxacin was ( 15.97± 2. 02) mm, and that of pretreatment was ( 18.88 ±1.99) mm,indicating that gatifloxacin inhibited the growth of NTM significantly (P 〈0.05 ). Combined therapy of gatifloxacin and amikacin enhanced the anti-microorganism effect ( 19.69±2. 16 mm^2 in pretreatment versus 15.05 - 3.80mm^2in posttreatment,P 〈0. Ol ). No significant differences were found in stromal infiltration area and clinical manifestation between before and after treatment of ciprofloxacin, Conclusion Gatifloxacin as well as the combination of gatifloxacin and amikacin are more effective to the treatment of NTM keratitis.
出处 《眼科研究》 CSCD 北大核心 2006年第5期530-533,共4页 Chinese Ophthalmic Research
基金 北京市卫生局科研基金资助(2004局009)
关键词 加替沙星 非结核分枝杆菌 角膜炎 动物模型 gatifloxacin non-tuberculous mycobacteria keratitis animal model
  • 相关文献

参考文献10

  • 1Brown EBA,Wallace RJ,Jr,Crist CJ,et al.Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria[J].Antimicrob Agents Chemother,2002,46:3283-3285
  • 2梁庆丰,李莹,邓世靖,王智群,李然,罗时运,孙旭光.准分子激光原位角膜磨镶术后非结核分枝杆菌性角膜炎一例[J].中华眼科杂志,2005,41(2):186-187. 被引量:17
  • 3The National Committee for Clinical Laboratory Standard.Susceptibility testing of mycobacteria,nocardia,and other aerobic actinomycetes.Tentative Standard-Second Edition[S].Wayne:NCCLS,2002,20 (26):1-59
  • 4阮克奋,童蟾素,王忠丽,张棣华.栀子滴眼液治疗兔眼石灰伤初步疗效观察[J].中国中医眼科杂志,1992,2(4):218-220. 被引量:7
  • 5Chung MS,Goldstein MH,Driebe WT,Jr,et al.Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal[J].Am J Ophthalmol,2000,129:382 -384
  • 6Pestova E,Millichap JJ,Noskin GA.Intracellular targets of moxi2 floxacin:a comparison with other fluoroquinolones[J].J Antimicrob Chemother,2000,45:583
  • 7Theomioka H,Saito H,Sato K.Comparative antimycobacterial activities of the newly synthesizel quinolone AM-1155,sparfloxacin,and ofloxacin[J].Antimicrob Agents Chemother,1993,37:1259
  • 8Ford JG,Huang AJW,Pflugfelder SC,et al.Nontuberculous mycobacterial keratitis in south Florida[J].Ophthalmology,1998,105:1652-1658
  • 9Eiferman RA,Stagner JI.Intraocular penetration of amikaein:iris binding and bioavailability[J].Arch Ophthalmol,1982,100:1817-1819
  • 10Levine JM,Noecker RJ,Lane LC.Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing[J].J Cataract Refract Surg,2004,30:2177-2182

二级参考文献5

  • 1Lin RT, Maloney RK. Flap complications associated with lamellar refractive surgery. Am J Ophthalmol, 1999, 127: 129-136.
  • 2Freitas D, Alvarenga L, Sampaio J, et al. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology, 2003, 110: 276-285.
  • 3Stulting RD, Carr JD, Thompson KP, et al. Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology, 1999, 127: 129-136.
  • 4Reviglio V, Rodriguez ML, Picotti GS, et al. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg, 1998, 14: 357-360.
  • 5Chung MS, Goldstein MH, Driebe WT Jr, et al. Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal. Am J Ophthalmol, 2000, 129: 382-384.

共引文献22

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部